Related Experiment Videos
The mastectomy clinical pathway: what has it achieved?
1Division of General Surgery, National University Hospital, 5 Lower Kent Ridge Road, Kent Ridge Wing, Level 5, Singapore 119074.
Annals of the Academy of Medicine, Singapore
|August 7, 2002
Summary
Implementing a mastectomy clinical pathway significantly reduced hospital stay and costs for breast cancer patients. The pathway improved treatment consistency and patient outcomes without increasing complication or readmission rates.
Area of Science:
- Oncology
- Healthcare Management
- Clinical Pathways
Background:
- Mastectomy clinical pathways aim to optimize care and cost management for breast cancer patients.
- This study prospectively evaluated a mastectomy pathway at a Singaporean hospital over seven months.
Purpose of the Study:
- To assess the impact of a mastectomy clinical pathway on patient care and cost management.
- To evaluate changes in length of stay, hospital costs, complication rates, and readmission rates.
Main Methods:
- A prospective study compared 83 patients on the mastectomy pathway (March-October 2001) with 69 control patients (March-October 2000).
- Key metrics analyzed included length of stay, hospital costs, complication incidence, and unscheduled readmissions.
Main Results:
- The pathway group showed a significant decrease in mean length of stay (4.91 to 4.10 days, P=0.018).
- Mean cost per case significantly reduced for the pathway group ($5,050 to $4,406, P=0.014).
- No significant differences were observed in complication or readmission rates between groups (P>0.05).
Conclusions:
- The mastectomy clinical pathway improved treatment consistency and patient outcomes.
- Pathway implementation led to reduced healthcare costs and shorter hospital stays.
- Variance analysis of the pathway is valuable for identifying areas to enhance patient care.